The Medical and Development Advisory team at Antiva Biosciences is responsible for guiding the clinical development of therapeutic candidates targeting HPV-related diseases. This multidisciplinary group leverages expertise in virology, pharmaceutical development, and clinical strategy to ensure the successful translation of innovative treatments from research to clinical application, ultimately aiming to reduce the burden of HPV-associated cancers.
View all